Stocks and Investing Stocks and Investing
Fri, July 30, 2021

Edward Tenthoff Maintained (VRTX) at Buy with Increased Target to $323 on, Jul 30th, 2021


Published on 2024-10-27 17:24:07 - WOPRAI, Edward Tenthoff
  Print publication without navigation


Edward Tenthoff of Piper Sandler, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $261 to $323 on, Jul 30th, 2021.

Edward has made no other calls on VRTX in the last 4 months.



There are 10 other peers that have a rating on VRTX. Out of the 10 peers that are also analyzing VRTX, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021


These are the ratings of the 9 analyists that currently disagree with Edward


  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $331 on, Monday, June 14th, 2021
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $307 on, Friday, June 11th, 2021
  • Mohit Bansal of "Citigroup" Maintained at Strong Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $244 on, Friday, June 11th, 2021
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $281 on, Friday, June 11th, 2021
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $240 on, Friday, June 11th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $279 on, Wednesday, May 12th, 2021
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $260 on, Monday, May 3rd, 2021
Contributing Sources